{"id":390952,"date":"2017-07-05T00:00:00","date_gmt":"2017-07-05T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/algoim0035-2017-biopharma-chronic-obstructive-pulmonary-disease-treatment-algorithms-claims-data-analysis-us-2017\/"},"modified":"2026-04-15T09:58:10","modified_gmt":"2026-04-15T09:58:10","slug":"algoim0035-2017-biopharma-chronic-obstructive-pulmonary-disease-treatment-algorithms-claims-data-analysis-us-2017","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/algoim0035-2017-biopharma-chronic-obstructive-pulmonary-disease-treatment-algorithms-claims-data-analysis-us-2017\/","title":{"rendered":"Chronic Obstructive Pulmonary Disease | Treatment Algorithms | Claims Data Analysis | US | 2017"},"content":{"rendered":"<p>The COPD treatment algorithm continues to evolve, with changing recommendations on the use of ICS s, LABA \/ ICS FDC s, and LABA \/ LAMA FDC s. This study reveals which therapies are prescribed first-line after diagnosis and how treatment evolves as patients move through additional lines of therapy. Both short-acting therapies and long-acting therapies are included, and many patients receive both rescue and maintenance therapies. Additionally, some patients receive a combination of a LAMA and a LABA \/ ICS FDC , and LABA \/ LAMA FDC s are beginning to gain traction in this.<\/p>\n","protected":false},"template":"","class_list":["post-390952","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-chronic-obstructive-pulmonary-disease","biopharma-product-treatment-algorithms-claims-data-analysis","biopharma-geography-us","biopharma-date-890"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390952\/revisions"}],"predecessor-version":[{"id":394076,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390952\/revisions\/394076"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=390952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}